GlassScriptPhysician profile
Alisha A Marchetti
NPI 1154658839
$2,391.96
in general payments reported to CMS, 2019-2025
27 companies · $771 in 2025
The $771 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $712 · 2024: $909 · 2025: $771.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $443.89 | 2023-2025 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $339.29 | 2023-2025 | |
| Teleflex LLC | $147.95 | 2023-2025 | Urolift, Barrigel |
| Coloplast Corp | $129.15 | 2023-2025 | Speedicath |
| Janssen Biotech, INC. | $121.57 | 2023-2025 | Erleada |
| Urogen Pharma, INC. | $120.56 | 2023-2024 | Jelmyto |
| Endo Pharmaceuticals INC. | $112.11 | 2023 | Xiaflex, Aveed |
| Astellas Pharma US INC | $111.26 | 2023-2024 | Xtandi, Myrbetriq |
| Ferring Pharmaceuticals INC. | $102.93 | 2024-2025 | Adstiladrin |
| Tempus Ai, INC | $98.84 | 2025 | Xt Cdx |
| Axonics, INC. | $98.03 | 2024 | Axonics |
| Dendreon Pharmaceuticals LLC | $87.39 | 2024-2025 | Provenge |
| Novo Nordisk INC | $62.67 | 2025 | Rivfloza |
| Progenics Pharmaceuticals, INC. | $51.92 | 2023-2024 | Pylarify |
| Abbvie INC. | $48.46 | 2024 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $41.32 | 2023 | Xgeva |
| Sun Pharmaceutical Industries INC. | $37.04 | 2023 | Yonsa, Odomzo |
| Astrazeneca Pharmaceuticals LP | $36.27 | 2023-2024 | Lynparza |
| Tolmar, INC. | $29.41 | 2023 | |
| Blue Earth Diagnostics | $25.54 | 2025 | Posluma |
| Koelis INC. | $25.29 | 2023 | |
| Cardinal Health 414 LLC | $23.87 | 2024 | |
| Laborie Medical Technologies Corp. | $21.63 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Merck Sharp & Dohme LLC | $21.55 | 2023 | Welireg, Keytruda, Lynparza |
| Palette Life Sciences, INC. | $20.58 | 2023 | |
| Endo USA, INC. | $17.78 | 2025 | Xiaflex, Aveed |
| Pfizer INC. | $15.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Marchetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.